Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 39 of Aprea Therapeutics, Inc.'s SEC filings and found 10 warrant series, 1 convertible, 2 ATM programs, 5 shelf registrations and 3 completed offerings on file for APRE. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
CNSPCNS Pharmaceuticals, Inc.
AIMAIM ImmunoTech Inc.
EVGNEVOGENE LTD.
TCRTAlaunos Therapeutics, Inc.
FBLGFibroBiologics, Inc. Common Stock
ENVBEnveric Biosciences, Inc.
XCURExicure, Inc.
SNTISenti Biosciences, Inc.
ACXPAcurx Pharmaceuticals, Inc.
ALZNAlzamend Neuro Inc
SKYESkye Bioscience, Inc.
CRISCuris, Inc.
ENSCEnsysce Biosciences, Inc.
OSRHOSR Holdings, Inc.
IMRNImmuron Limited American Depositary Shares